SALA, GESSICA
 Distribuzione geografica
Continente #
NA - Nord America 7.350
EU - Europa 4.313
AS - Asia 1.848
SA - Sud America 108
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 3
Totale 13.649
Nazione #
US - Stati Uniti d'America 7.227
IT - Italia 972
DE - Germania 741
SG - Singapore 732
CN - Cina 584
RU - Federazione Russa 579
SE - Svezia 533
IE - Irlanda 397
UA - Ucraina 307
GB - Regno Unito 227
HK - Hong Kong 181
AT - Austria 130
CA - Canada 116
FI - Finlandia 103
BR - Brasile 90
IN - India 90
FR - Francia 73
PL - Polonia 53
VN - Vietnam 53
NL - Olanda 49
DK - Danimarca 47
ID - Indonesia 47
BE - Belgio 42
IR - Iran 39
TR - Turchia 35
JP - Giappone 24
KR - Corea 19
CH - Svizzera 9
CZ - Repubblica Ceca 9
EU - Europa 9
ES - Italia 8
PT - Portogallo 7
AR - Argentina 6
MX - Messico 6
PK - Pakistan 6
TW - Taiwan 6
EG - Egitto 5
GR - Grecia 5
PE - Perù 5
RO - Romania 5
LT - Lituania 4
PH - Filippine 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
HU - Ungheria 3
IL - Israele 3
NO - Norvegia 3
CL - Cile 2
CY - Cipro 2
DZ - Algeria 2
EE - Estonia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MU - Mauritius 2
MY - Malesia 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
VE - Venezuela 2
A1 - Anonimo 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CO - Colombia 1
GA - Gabon 1
IQ - Iraq 1
KH - Cambogia 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
NP - Nepal 1
OM - Oman 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
Totale 13.649
Città #
Ann Arbor 1.609
Woodbridge 679
Chandler 545
Singapore 497
Frankfurt am Main 488
Houston 482
Ashburn 396
Fairfield 392
Dublin 381
Jacksonville 343
Wilmington 319
Milan 316
Dearborn 263
Santa Clara 225
New York 212
Hong Kong 177
Seattle 167
Princeton 152
Cambridge 137
Vienna 121
Shanghai 106
Nanjing 90
Boardman 68
Lachine 61
Altamura 53
Lawrence 47
Jakarta 45
Kraków 44
Beijing 42
Brussels 41
Fremont 36
Guangzhou 34
Helsinki 34
Shenyang 31
Moscow 30
Pisa 30
Council Bluffs 28
Nanchang 27
Dong Ket 26
Rome 26
San Diego 26
Changsha 25
Los Angeles 25
Andover 24
Jinan 24
Falls Church 22
Hebei 22
Tianjin 22
Grafing 21
Monza 21
Munich 21
Pune 21
Turin 21
Jiaxing 19
Lecco 19
London 19
Toronto 19
Dallas 18
Ottawa 18
Zhengzhou 18
Tehran 16
Ningbo 13
Mountain View 12
The Dalles 12
Norwalk 11
Auburn Hills 10
Como 10
Lissone 10
Cinisello Balsamo 9
Detroit 9
Düsseldorf 9
Edmonton 9
Hangzhou 9
Huizen 9
Kunming 9
Belo Horizonte 8
Bologna 8
Brno 8
Desio 8
Hefei 8
Itaborai 8
Nuremberg 8
Redmond 8
Zurich 8
Bari 7
Naples 7
Nürnberg 7
Florence 6
Lappeenranta 6
Paderno Dugnano 6
Pioltello 6
Rho 6
San Mateo 6
Seregno 6
Zanjan 6
Amsterdam 5
Hyderabad 5
Leawood 5
Monmouth Junction 5
Taipei 5
Totale 9.548
Nome #
ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability 480
NMR-driven identification of anti-amyloidogenic compounds in green and roasted coffee extracts 382
Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease 333
Oxidative stress and altered mitochondrial dynamics in neurodegenerative processes 296
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 282
NMR-based Lavado cocoa chemical characterization and comparison with fermented cocoa varieties: insights on cocoa’s anti-amyloidogenic activity 263
Ischemic Conditions Affect Rerouting of Tau Protein Levels: Evidences for Alteration in Tau Processing and Secretion in Hippocampal Neurons 261
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 258
Reduced platelet glutamate uptake in Parkinson's disease 249
HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation 231
Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition 219
Rotenone-induced down-regulation of HSPA8/hsc70 protein increases alphasynuclein in vitro: possible implications for Parkinson’s disease 218
Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients 213
Peripheral cytokine release in Alzheimer patients: Correlation with disease severity 212
In vitro study of autophagy dysfunctions associated with Parkinson’s disease 210
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 209
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 204
Study of alpha-synuclein and its catabolic pathways in ex vivo cells of patients with Parkinson’s disease 199
Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson's disease 190
Platelet glutamate uptake as peripheral marker of excitotoxicity in neurodegenerative disorders 189
Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines 187
Rotenone down-regulates hspa8/hsc70 protein in vitro: a new possible toxic mechanism contributing to Parkinson’s disease 186
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 185
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 184
AUTOPHAGY ALTERATION UNDER ISCHEMIC CONDITION: A POSSIBLE LINK TO ALZHEIMER'S DISEASE 184
Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease 184
Alpha-Synuclein, Oxidative Stress and Autophagy Failure: Dangerous Liaisons in Dopaminergic Neurodegeneration 183
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 183
Effect of mitochondrial complex I inhibition on chaperone-mediated and myocyte enhancer factor 2D in human neuroblastoma cells 182
Study Of Chaperone Mediated Autophagy in Lymphomonocytes of sporadic and familial als patients evidenced Hsc70 reduction and TDP-43 aggregation 182
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 180
Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts 178
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 178
Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease 174
NMR-driven identification of cinnamon bud and bark components with anti-Aβ activity 174
A panel of macroautophagy markers in lymphomonocytes of patients with amyotrophic lateral sclerosis 173
Huntington's disease and HDACi: Would sulpiride and valproate be of therapeutic value? 171
Nerve growth factor and transforming growth factor-β serum levels in acute stroke patients: Possible involvement of neurotrophins in cerebrovascular disease 170
MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients 170
Ischemic injury elicits the unconventional secretion of protein hallmarks of Alzheimer's disease onset as seeds for interneuronal propagation 167
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 167
Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases 165
Reduced expression of hsc70 protein in lymphomonocytes of patients with Parkinson's disease 164
Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine 163
Exploring the role of autophagy in the pathogenesis of rotenone-induced toxicity 157
A Preliminary Study of Chaperone-Mediated Autophagy in ALS Lymphomonocytes 156
Assessment of chaperone-mediated autophagy in circulating lymphomonocytes of patients with Parkinson disease 155
MEF2C and MEF2D alterations in sporadic and familial ALS patients: a possible correlation with disease progression? 153
MEF2D and MEF2C Pathways Disruption in Sporadic and Familial ALS Patients 151
Study of alpha-synuclein and its catabolic pathways in lymphomonocytes of patients with Parkinson's disease 149
Alzheimer's Disease Prevention through Natural Compounds: Cell-Free, in Vitro, and in Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity 147
Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON) 146
Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro 145
Analysis of glutamate transporters in peripheral cells: A tool to invistigate excitotoxicity in neurodegenerative disorders 144
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 144
New insights into the genetic etiology of Alzheimer's disease and related dementias 144
Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson’s disease 141
Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis 139
Macroautophagy is not altered in ALS lymphomonocytes 139
the MonzALS collaborative network 139
Chaperone mediated autophagy in Parkinson's disease: Study in peripheral blood cells from patients and in a cellular model 134
Mef2d-mef2c pathways are altered in lymphomonocytes of patients with sporadic and familial form of amyotrophic lateral sclerosis 134
Digested Cinnamon (Cinnamomum verum J. Presl) Bark Extract Modulates Claudin-2 Gene Expression and Protein Levels under TNFα/IL-1β Inflammatory Stimulus 132
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 130
Increased interleukin-6 release from peripheral blood cells of patients after brain trauma 130
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 126
HSPA8 knock-down induces the accumulation of neurodegenerative disorder-associated proteins 126
Dysfunction of chaperone-mediated autophagy in lymphomonocytes from patients with Parkinson's disease and in a cellular model 120
Whole-blood global DNA methylation and phenotypic variability in ALS 120
Assessing glutamatergic function and dysfunction in peripheral tissues 118
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion 117
Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids 116
Myocyte Enhacer Factor-2 Pathway Is Altered In Amyotrophic Lateral Sclerosis Peripheral Blood Mononuclear Cells 116
Interactions between excitotoxicity and oxidative stress in ALS: clues for pharmacotherapy 115
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset 112
Recent advances in the therapy of amyotrophic lateral sclerosis: Focus on excitotoxicity 108
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid 102
Platelets 85
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) 60
Core blood biomarkers of Alzheimer's disease: A single-center real-world performance study 56
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 52
Author Correction: Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro (Scientific Reports, (2021), 11, 1, (2197), 10.1038/s41598-021-81693-8) 51
Neuroprotection and Non-Invasive Brain Stimulation: Facts or Fiction? 40
Totale 14.081
Categoria #
all - tutte 47.550
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.550


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020262 0 0 0 0 0 0 0 0 0 109 119 34
2020/20211.498 86 86 145 182 107 81 134 131 132 173 98 143
2021/20221.120 97 126 109 100 81 113 45 57 50 69 108 165
2022/20232.119 190 615 193 239 163 321 26 117 144 17 50 44
2023/20241.674 81 79 104 88 201 456 239 90 79 14 31 212
2024/20252.468 170 407 276 135 253 185 161 139 318 424 0 0
Totale 14.081